Search research articles
Contact Us
Filters
Showing results (921-930 of 964) with videos related to
Page
of 97
Sort By:
British Journal of Cancer
|
April 16, 2002
Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma
M Kaya, T Wada, S Kawaguchi, et al.
Oncogene
|
October 26, 2005
Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability
K Koinuma, Y Yamashita, W Liu, et al.
Clinical and Experimental Immunology
|
December 2, 2008
Analysis of T cell receptor Vbeta diversity in peripheral CD4 and CD8 T lymphocytes in patients with autoimmune thyroid diseases
M Okajima, T Wada, M Nishida, et al.
Gastroenterologia Japonica
|
January 1, 1980
On the condition and activities of Jeddah Endoscopy Center
H A Gezairy, T Wada, Y Oguro, et al.
Kidney International
|
September 1, 1999
MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis
T Wada, K Furuichi, C Segawa-Takaeda, et al.
Blood
|
April 16, 1998
A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma
H Kanegane, K Bhatia, M Gutierrez, et al.
Clinical and Experimental Immunology
|
March 22, 2007
Clonotypic analysis of T cell reconstitution after haematopoietic stem cell transplantation (HSCT) in patients with severe combined immunodeficiency
H Okamoto, C Arii, F Shibata, et al.
Cell Death and Differentiation
|
June 18, 2011
Plasma membrane-associated sialidase (NEU3) regulates progression of prostate cancer to androgen-independent growth through modulation of androgen receptor signaling
S Kawamura, I Sato, T Wada, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology
|
February 17, 1999
[A clinical study of decreased bone density in the patients treated with long-term luteinizing hormone releasing hormone analogue (LHRH-a)--the risk of iatrogenic osteoporosis due to treatment of carcinoma of prostate]
Y Suzuki, K Aikawa, Y Oishi, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
August 31, 2000
[Clinical statistics on patients and operations during a 20-year period (1978-1997) at Department of Urology, Jikei University School of Medicine]
I Ikemoto, Y Ohishi, S Onodera, et al.
Page
of 97
Search research articles
Search
Showing results (921-930 of 964) with videos related to
Sort By:
Page
of 97
British Journal of Cancer
|
April 16, 2002
Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma
M Kaya, T Wada, S Kawaguchi, et al.
Oncogene
|
October 26, 2005
Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability
K Koinuma, Y Yamashita, W Liu, et al.
Clinical and Experimental Immunology
|
December 2, 2008
Analysis of T cell receptor Vbeta diversity in peripheral CD4 and CD8 T lymphocytes in patients with autoimmune thyroid diseases
M Okajima, T Wada, M Nishida, et al.
Gastroenterologia Japonica
|
January 1, 1980
On the condition and activities of Jeddah Endoscopy Center
H A Gezairy, T Wada, Y Oguro, et al.
Kidney International
|
September 1, 1999
MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis
T Wada, K Furuichi, C Segawa-Takaeda, et al.
Blood
|
April 16, 1998
A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma
H Kanegane, K Bhatia, M Gutierrez, et al.
Clinical and Experimental Immunology
|
March 22, 2007
Clonotypic analysis of T cell reconstitution after haematopoietic stem cell transplantation (HSCT) in patients with severe combined immunodeficiency
H Okamoto, C Arii, F Shibata, et al.
Cell Death and Differentiation
|
June 18, 2011
Plasma membrane-associated sialidase (NEU3) regulates progression of prostate cancer to androgen-independent growth through modulation of androgen receptor signaling
S Kawamura, I Sato, T Wada, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology
|
February 17, 1999
[A clinical study of decreased bone density in the patients treated with long-term luteinizing hormone releasing hormone analogue (LHRH-a)--the risk of iatrogenic osteoporosis due to treatment of carcinoma of prostate]
Y Suzuki, K Aikawa, Y Oishi, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
August 31, 2000
[Clinical statistics on patients and operations during a 20-year period (1978-1997) at Department of Urology, Jikei University School of Medicine]
I Ikemoto, Y Ohishi, S Onodera, et al.
Page
of 97